负载氢氧化钙的PLGA可降解纳米颗粒作为根管内药物
本研究开发了负载氢氧化钙的PLGA可降解纳米颗粒,优化并表征了其性质,比较了其与游离氢氧化钙的药物释放曲线及在离体牙牙本质小管中的渗透深度和面积。结果显示纳米颗粒平均粒径小于200 nm,多分散指数低于0.2,具有高负zeta电位和合适包封率,药物释放持续稳定达48小时且浓度高于游离氢氧化钙,在牙本质小管中的渗透深度和面积显著大于游离药物。
要点
- 负载氢氧化钙的PLGA纳米颗粒平均粒径小于200 nm,多分散指数低于0.2。
- 纳米颗粒药物释放持续稳定达48小时,浓度高于游离氢氧化钙。
- 纳米颗粒在牙本质小管中的渗透深度和面积显著大于游离氢氧化钙。
核心结论
- 负载氢氧化钙的PLGA纳米颗粒成功优化并表征,具有延长药物释放和优于游离氢氧化钙的牙本质小管渗透能力。
研究设计与样本
- 采用溶剂置换法制备氢氧化钙纳米颗粒,并通过中心复合设计优化处方。
- 使用透射电镜、X射线衍射、傅里叶变换红外光谱和差示扫描量热法表征纳米颗粒。
- 评估纳米颗粒与游离氢氧化钙在48小时内的药物释放曲线。
- 比较两者在离体牙牙本质小管中的渗透深度和面积,使用Mann-Whitney U检验分析差异。
主要发现
- 优化后纳米颗粒平均粒径小于200 nm,多分散指数低于0.2,具有高负zeta电位和合适包封率。
- 透射电镜确认纳米颗粒为球形,XRD、FTIR和DSC结果显示药物被包裹且无相互作用。
- 纳米颗粒药物释放持续稳定达48小时,浓度高于游离氢氧化钙。
- 共聚焦激光扫描显微镜显示纳米颗粒在牙本质小管中的渗透深度和面积显著大于游离氢氧化钙。
临床怎么用
- 该纳米颗粒制剂有望作为根管内药物,提供延长释放和更深的牙本质小管渗透。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To develop a formulation in which calcium hydroxide (Ca(OH)₂) was successfully loaded into poly(lactic-co-glycolic acid) (PLGA) biodegradable nanoparticles (NPs) to be used in the field of endodontics as an intracanal medicament, including NP optimization and characterization, plus drug release profile of the NPs compared with free Ca(OH)₂. Additionally, the depth and area of penetration of the NPs inside the dentinal tubules of extracted teeth were compared with those of the free Ca(OH)₂. METHODOLOGY: Ca(OH)₂ NPs were prepared using the solvent displacement method. NPs was optimized with a central composite design to obtain a final optimized formulation. The morphology of the NPs was examined under transmission electron microscopy (TEM), and characterization was carried out using X-ray diffraction (XRD), Fourier transform infrared (FTIR) and differential scanning calorimetry (DSC). The drug release profile of the Ca(OH)₂ NPs and free Ca(OH)₂ was evaluated up to 48 h. Finally, the depth and area of penetration inside the dentinal tubules of extracted teeth were examined for both the Ca(OH)₂ NPs and free Ca(OH)₂ using the Mann-Whitney U test to determine any significant differences. RESULTS: Utilizing the optimized formulation, the Ca(OH)₂ NPs had an average size below 200 nm and polydispersity index lower than 0.2, along with a highly negative zeta potential and suitable entrapment efficiency percentage. The spherical morphology of the Ca(OH)₂ NPs was confirmed using TEM. The results of the XRD, FTIR and DSC revealed no interactions and confirmed that the drug was encapsulated inside the NPs. The drug release profile of the Ca(OH)₂ NPs exhibited a prolonged steady release that remained stable up to 48 h with higher concentrations than the free Ca(OH)₂. After examination by confocal laser scanning microscopy, Ca(OH)₂ NPs had a significantly greater depth and area of penetration inside dentinal tubules compared with the free drug. CONCLUSIONS: Ca(OH)₂-loaded PLGA NPs were successfully optimized and characterized. The NPs exhibited a prolonged drug release profile and superior penetration inside dentinal tubules of extracted teeth when compared to Ca(OH)2 .
引用
- Elmsmari F, González Sánchez JA, Duran-Sindreu F, et al. Calcium hydroxide-loaded PLGA biodegradable nanoparticles as an intracanal medicament. Int Endod J. 2021. PMID: 34355406. doi:10.1111/iej.13603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。